Banque Cantonale Vaudoise’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Banque Cantonale Vaudoise's NVO Position: Q1 2026 in Review
Banque Cantonale Vaudoise increased its Novo Nordisk (NVO) stake by 33% in Q1 2026, buying an estimated $342K and bringing the position to 29,164 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #365.
Banque Cantonale Vaudoise first reported a position in NVO in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.4M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Banque Cantonale Vaudoise held 29,164 shares of Novo Nordisk worth $1.07M as of Q1 2026.
- Banque Cantonale Vaudoise bought 7,209 Novo Nordisk shares in Q1 2026, an estimated $342K.
- Novo Nordisk made up 0.04% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #365 holding.
- Banque Cantonale Vaudoise first reported a position in Novo Nordisk in Q2 2021 and has held it in 19 quarters since.
- Banque Cantonale Vaudoise's Novo Nordisk position peaked at $1.4M in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.